Abstract
Characterization of tumor processes and studying their metabolism is one of the main challenges in diagnostic clinical oncology. Magnetic resonance spectroscopy (MRS) provides a noninvasive method to monitor tissue metabolism. Since the early work of Griffiths [1], an increasing number of papers have been published on in vivo measurement of tumor metabolism using MRS. Detailed accounts of the methods of NMR spectroscopy and NMR imaging have been published [2,3] and are beyond the scope of this review.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Griffiths JR, Cady E, Edwards RTH, et al. 31-P NMR studies of a human tumor in situ (letter). Lancet 1:1435–1436, 19.
Koutcher JA, Burt CT. Principles of nuclear magnetic resonance. J. Nuclear Med 25:101–111, 1984.
Rosen BR, Brady TJ. Principles of nuclear magnetic resonance for medical application. Semin Nuclear Med 13:308–318, 1983.
Gadian DG. Nuclear Magnetic Resonance and its Applications to Living Systems. Oxford University Press, New York, 1982.
Evanochko WT, Sakai T, N TC, et al. NMR study of in vivo RIF-1 tumors: analysis of perchloric acid extracts and identification of 1H, 31P and 13C resonances. Biochem Biophys Acta 805:104–116, 1984.
Daly PF, Lyon RC, Faustino PJ, Cohen JS. Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. J. Biol Chem 262:2596–2604, 1987.
Ross B, Helsper JT, Cox J, et al. Osteosarcoma and other neoplasms of bone. Magnetic resonance spectroscopy to monitor therapy. Arch Surg 122:1464–1469, 1987.
Redmond OM, Stack JP, Dervan PA, et al. Osteosarcoma: use of MR imaging and MR spectroscopy in clinical decision making. Radiology 172:811–815, 1989.
Zlatkin MB, Lenkinski RE, Shikwain M, et al. Combined MR imaging and spectroscopy of bone and soft tissue tumors. J Computed Tomogr 14:1–10, 1990.
Koutcher JA, Ballon D, Graham M, et al. 31P NMR spectra of extremity sarcomas: diversity of metabolic profiles and changes in response to chemotherapy. Magnetic Res Med 16:19–34, 1990.
Just M, Gutjahr P, Juretschke HP, et al. 31P phosphospectroscopie bei osteogenem sarkom. Fortschr Roentgenstr 146:144–148, 1987.
Lenkinski RE, Listerud J, Shinkwin MA, et al. Magnetic resonance imaging and magnetic resonance spectroscopy of bone tumors and bone marrow disease. Invest Radiol 24:1006–1010, 1989.
Boeve WJ, Kamman RL, Mooyaart EL, et al. In vivo phosphorous magnetic resonance spectroscopy of bone and soft tissue tumors. In 8th Annual Meeting of the Society of MRM. Book of Abstracts, 549, 1989.
Boeve WJ, Hoekstra HJ, Kamman RL, et al. The clinical value of in vivo 31-phosphorous magnetic resonance spectroscopy (MRS) of bone and soft tissue tumors. Am Soc Clin Oncol, 1991.
Semmler W, Gademan G, Bachert-Baumann P, et al. Monitoring human tumor response to therapy by means of P-31 MR spectroscopy. Radiology 166:533–539, 1988.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mooyaart, E.L., Kamman, R.L., Boeve, W.J. (1993). In vivo 31P nuclear magnetic resonance spectroscopy of osteosarcoma. In: Humphrey, G.B., Koops, H.S., Molenaar, W.M., Postma, A. (eds) Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies. Cancer Treatment and Research, vol 62. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3518-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3518-8_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6561-7
Online ISBN: 978-1-4615-3518-8
eBook Packages: Springer Book Archive